Incannex Healthcare Inc (NASDAQ: IXHL)’s stock price has plunge by -4.55relation to previous closing price of 0.22. Nevertheless, the company has seen a 3.96% surge in its stock price over the last five trading sessions. globenewswire.com reported 2025-05-29 that NEW YORK and MELBOURNE, Australia, May 29, 2025 (GLOBE NEWSWIRE) — Incannex Healthcare Inc. (Nasdaq: IXHL), a clinical-stage pharmaceutical company developing novel combination therapies, today announced that the Phase 3 component of the RePOSA clinical trial will proceed. The U.S. Food and Drug Administration (FDA) previously reviewed and authorized the protocol to proceed under the Company’s Investigational New Drug (IND) application.
Is It Worth Investing in Incannex Healthcare Inc (NASDAQ: IXHL) Right Now?
Moreover, the 36-month beta value for IXHL is 2.51. Analysts have varying opinions on the stock, with 0 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
On June 02, 2025, IXHL’s average trading volume was 46.44M shares.
IXHL’s Market Performance
IXHL stock saw an increase of 3.96% in the past week, with a monthly gain of 42.08% and a quarterly increase of -83.46%. The volatility ratio for the week is 15.89%, and the volatility levels for the last 30 days are 54.45% for Incannex Healthcare Inc (IXHL). The simple moving average for the past 20 days is 1.10% for IXHL’s stock, with a -85.65% simple moving average for the past 200 days.
IXHL Trading at -52.95% from the 50-Day Moving Average
After a stumble in the market that brought IXHL to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -94.08% of loss for the given period.
Volatility was left at 54.45%, however, over the last 30 days, the volatility rate increased by 15.89%, as shares surge +58.01% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -75.61% lower at present.
During the last 5 trading sessions, IXHL rose by +3.96%, which changed the moving average for the period of 200-days by -89.34% in comparison to the 20-day moving average, which settled at $0.2077. In addition, Incannex Healthcare Inc saw -90.09% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for IXHL
Current profitability levels for the company are sitting at:
- -614.5 for the present operating margin
- 1.0 for the gross margin
The net margin for Incannex Healthcare Inc stands at -514.79. The total capital return value is set at -2.8. Equity return is now at value -201.88, with -130.01 for asset returns.
Based on Incannex Healthcare Inc (IXHL), the company’s capital structure generated 0.81 points at debt to capital in total, while cash flow to debt ratio is standing at -1.92. The debt to equity ratio resting at 4.25. The interest coverage ratio of the stock is -86.25.
Currently, EBITDA for the company is -18.5 million with net debt to EBITDA at -0.18. When we switch over and look at the enterprise to sales, we see a ratio of 903.13. The liquidity ratio also appears to be rather interesting for investors as it stands at 2.12.
Conclusion
To wrap up, the performance of Incannex Healthcare Inc (IXHL) has been mixed in recent times. The stock has received a mixed of “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
